“While the jury’s $130 million verdict is significant and may sound large in the abstract, it may not be enough without enhancement to deter infringing conduct given the context of this case,” Judge Olguin wrote. Evidence presented at trial shows that the infringing products sold by Cochlear generated $1.8 billion in revenues. Cochlear had publicly stated in a 2016 annual report that the jury’s verdict won’t disrupt Cochlear’s business or U.S. customers.
The post Judge Awards Enhancement of Damages to $268 Million in Cochlear Implant Patent Case appeared first on IPWatchdog.com | Patents & Patent Law.
Judge Awards Enhancement of Damages to $268 Million in Cochlear Implant Patent Case
No Comments
Patent
- Enablement
- Fee Shifting
- Litigation
- One Way or Another, Arthrex Promises to Put the PTAB on Trial
- Federal Circuit Reverses District Court Finding that ‘Check Data’ Patent is Abstract
- Netlist Wins ITC Exclusion Order: Will the USPTO Support It?
- The Problem of IPR Infringement in India’s Burgeoning Startup Ecosystem
- Other Barks & Bites, Friday, November 15: SCOTUS to Hear Booking.com Trademark Case, AG Barr Backs FCC Plan Against Huawei and ZTE, Copyright Office Eliminates Physical Material Submission Options
Recent Posts
- One Way or Another, Arthrex Promises to Put the PTAB on Trial
- Federal Circuit Reverses District Court Finding that ‘Check Data’ Patent is Abstract
- Netlist Wins ITC Exclusion Order: Will the USPTO Support It?
- The Problem of IPR Infringement in India’s Burgeoning Startup Ecosystem
- Other Barks & Bites, Friday, November 15: SCOTUS to Hear Booking.com Trademark Case, AG Barr Backs FCC Plan Against Huawei and ZTE, Copyright Office Eliminates Physical Material Submission Options